| Literature DB >> 31206961 |
Judith Schlagnitweit1, Sarah Friebe Sandoz1, Aleksander Jaworski2, Ileana Guzzetti1, Fabien Aussenac3, Rodrigo J Carbajo4, Elisabetta Chiarparin4, Andrew J Pell2, Katja Petzold1.
Abstract
Gaining insight into the uptake, trafficking and target engagement of drugs in cells can enhance understanding of a drug's function and efficiency. However, there are currently no reliable methods for studying untagged biomolecules in macromolecular complexes in intact human cells. Here we have studied an antisense oligonucleotide (ASO) drug in HEK 293T and HeLa cells by NMR spectroscopy. Using a combination of transfection, cryoprotection and dynamic nuclear polarization (DNP), we were able to detect the drug directly in intact frozen cells. Activity of the drug was confirmed by quantitative reverse transcription polymerase chain reaction (qRT-PCR). By applying DNP NMR to frozen cells, we overcame limitations both of solution-state in-cell NMR spectroscopy (e.g., size, stability and sensitivity) and of visualization techniques, in which (e.g., fluorescent) tagging of the ASO decreases its activity. The capability to detect an untagged, active drug, interacting in its natural environment, represents a first step towards studying molecular mechanisms in intact cells.Entities:
Keywords: antisense agents; dynamic nuclear polarization; in-cell NMR spectroscopy; nucleic acids; oligonucleotides
Year: 2019 PMID: 31206961 DOI: 10.1002/cbic.201900297
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164